The efficient expression of human fibroblast collagenase in Escherichia coli and the discovery of flavonoid inhibitors

被引:11
作者
Lu, Weiqiang [1 ]
Zhu, Junsheng [1 ]
Zou, Shien [2 ]
Li, Xi [1 ]
Huang, Jin [1 ]
机构
[1] E China Univ Sci & Technol, Sch Pharm, Shanghai Key Lab Chem Biol, Shanghai 200237, Peoples R China
[2] Fudan Univ, Obstet & Gynecol Hosp, Shanghai 200433, Peoples R China
基金
高等学校博士学科点专项科研基金; 中国国家自然科学基金;
关键词
MMP-1; catalytic domain; soluble expression; flavonoids; MATRIX-METALLOPROTEINASE INHIBITORS; CATALYTIC DOMAIN; TISSUE INHIBITOR; PROCOLLAGENASE; IDENTIFICATION; STROMELYSIN; ACTIVATION; DISEASES; CANCER; CELLS;
D O I
10.3109/14756366.2012.681650
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human skin fibroblast collagenase also known as Matrix Metalloproteinase-1 (MMP-1) is a key enzyme in remodeling and degradation of extracellular matrix, and the inhibitors of human MMP-1 are effective drug candidates for the treatment of cancer. In this study, we report an improved method for high-level expression of soluble human MMP-1 catalytic domain (cd-MMP-1) in E. coli. The enzymatic activity is found maximum at pH 7.5 and temperature 40 degrees C with a K-m value of 13.02 mu M. Effects of 17 structure-related flavonoids on MMP-1 activity are evaluated using a fluorescent assay, 6 inhibitors are identified with IC50 < 10 mu M. Fisetin is the most active agent with an IC50 value of 1.35 mu M and is identified as a mixed type inhibitor. Our improved soluble cd-MMP-1 expression method provides a basis for inhibitors identification and may be beneficial to discover novel anti-cancer agent targeting human MMP-1.
引用
收藏
页码:741 / 746
页数:6
相关论文
共 24 条
[1]   Inhibitory Effect of Flavonoids on 26S Proteasome Activity [J].
Chang, Tsui-Ling .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2009, 57 (20) :9706-9715
[2]   Identification of the 183RWTNNFREY191 region as a critical segment of matrix metalloproteinase 1 for the expression of collagenolytic activity [J].
Chung, L ;
Shimokawa, K ;
Dinakarpandian, D ;
Grams, F ;
Fields, GB ;
Nagase, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (38) :29610-29617
[3]   THE USE OF ENGINEERED E1A GENES TO TRANSACTIVATE THE HCMV-MIE PROMOTER IN PERMANENT CHO CELL-LINES [J].
COCKETT, MI ;
BEBBINGTON, CR ;
YARRANTON, GT .
NUCLEIC ACIDS RESEARCH, 1991, 19 (02) :319-325
[4]   Ischemia-induced cleavage of cadherins in NRK cells requires MT1-MMP (MMP-14) [J].
Covington, MD ;
Burghardt, RC ;
Parrish, AR .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2006, 290 (01) :F43-F51
[5]   New functions for the matrix metalloproteinases in cancer progression [J].
Egeblad, M ;
Werb, Z .
NATURE REVIEWS CANCER, 2002, 2 (03) :161-174
[6]   Inhibition of matrix metalloproteinase-2 and-9 activities by selected flavonoids [J].
Encle, C ;
Gebhardt, R .
PLANTA MEDICA, 2004, 70 (10) :1006-1008
[7]   INCREASED EXPRESSION OF MATRIX METALLOPROTEINASES AND MATRIX-DEGRADING ACTIVITY IN VULNERABLE REGIONS OF HUMAN ATHEROSCLEROTIC PLAQUES [J].
GALIS, ZS ;
SUKHOVA, GK ;
LARK, MW ;
LIBBY, P .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (06) :2493-2503
[8]   CHARACTERIZATION OF THE PHE-81 AND VAL-82 HUMAN FIBROBLAST COLLAGENASE CATALYTIC DOMAIN PURIFIED FROM ESCHERICHIA-COLI [J].
GEHRING, MR ;
CONDON, B ;
MARGOSIAK, SA ;
KAN, CC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (38) :22507-22513
[9]  
GRANT GA, 1987, J BIOL CHEM, V262, P5886
[10]   Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases [J].
Hu, Jialiang ;
Van den Steen, Philippe E. ;
Sang, Qing-Xiang A. ;
Opdenakker, Ghislain .
NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (06) :480-498